Status:
UNKNOWN
Randomized Controlled Trial of the Myndlift BPT App
Lead Sponsor:
New York University
Collaborating Sponsors:
Myndlift Ltd.
Conditions:
ADHD
Behavioral Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
We propose addressing these aims by conducting a randomized controlled trial (RCT) that will evaluate the hybrid BPT (Myndlift BPT) compared to a wait-list control group. All participants will receive...
Detailed Description
Over the past several decades, much of the literature on attention-deficit/hyperactivity disorder (ADHD) and other disruptive behavior disorders (DBDs; i.e., conduct disorder/CD and oppositional defia...
Eligibility Criteria
Inclusion
- the child must be between the ages of 3-11 at the time of baseline/pretreatment data collection;
- the child must have an elevated score based on parent-report on the Inattention and/or Hyperactivity/Impulsivity Symptom Index of the ADHD Rating Scale- 5 (Dupual et al., 2016)
- the parent/caregiver must be a fluent English speaker;
- the parent/caregiver must be the legal guardians of and have full-time child care responsibilities for their child (parents/caregiver with limited contact with their child will not have the opportunity to sufficiently practice the BPT skills),
- the parent/caregiver must have reliable and stable mobile internet access,
- the parent/caregiver must use an Apple iOS operating system (Myndlift BPT is only available in iOS 9 or above) the parent/caregiver and their child must reside in the United States.
Exclusion
- the child or parent/caregiver presents with emergency psychiatric needs that require services beyond those that can be managed within this intervention format (e.g., hospitalization, specialized placement outside the home); In this case, an active intervention by research staff to secure what is needed will be made;
- if the child has an elevated score for Autism Spectrum Disorder on the Developmental Behavior Checklist-Autism Screening Algorithm (youth with ASD often require considerably more intervention; and,
- if the parent/caregiver is currently enrolled or has recently enrolled in any type of BPT program (i.e., past two years).
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05182424
Start Date
January 1 2022
End Date
June 30 2022
Last Update
January 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York University
New York, New York, United States, 10003